The World Organisation for Animal Health (WOAH) recently declared Taiwan as a non-epidemic zone for the three major swine diseases: African swine fever, classical swine fever and foot-and-mouth disease. This signifies that its biosecurity measures have reached international standards, a milestone made possible through continuous technological innovation.

News Media – Live coverage from the exhibition. 
Source: The Liberty Times

Fully aligned with Taiwan’s national efforts, HIPRA has demonstrated how innovation in animal health can serve as a critical pillar in disease control and in improving the competitiveness of the livestock industry on a global scale. 

At the recent Yunlin Swine Industry Expo—Taiwan’s premier event showcasing the latest developments in swine farming, management, and biotechnology—HIPRA presented HIPRADERMIC®, a next-generation needle-free device designed for intradermal vaccine administration. Utilizing high-pressure technology, HIPRADERMIC® delivers vaccines directly into the dermal layer, ensuring a robust immune response while eliminating the risk of iatrogenic cross-contamination associated with traditional needle-based methods. 

The deployment of technologies like HIPRADERMIC® reinforces HIPRA’s commitment to advanced biosecurity practices and aligns directly with Taiwan’s newly granted non-epidemic zone status. At the same time, it underscores HIPRA’s position as a global leader in disease prevention and animal health innovation.

Source: Captured from PTS News coverage

With a steadfast commitment to delivering high-quality vaccines and integrated biosecurity solutions, HIPRA continues to support the transformation of the livestock sector towards safer, more sustainable, and technologically advanced production models.